Evidence map›Paper›PMID 42303311›Full record

ArticleBMJ open respiratory research2026

Impact of indoor exposure to particulate matter on the progression of idiopathic pulmonary fibrosis: a prospective multicentre cohort study protocol.

Hee-Young Yoon, Ju Hyun Oh, Won-Il Choi, Sun Mi Choi, Jimyung Park, Yong Suk Jo, Sung Woo Park, Jae Ha Lee, Hyun-Kyung Lee, Song Yee Kim and 10 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hee-Young Yoon *Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Yongsan-gu, Seoul, South Korea.ORCID http://orcid.org/0000-0001-9852-0036
Ju Hyun Oh *Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, South Korea.
Won-Il ChoiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Gyeonggi-do, South Korea.
Sun Mi ChoiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Jongno-gu, Seoul, South Korea.ORCID http://orcid.org/0000-0002-0742-6085
Jimyung ParkDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Jongno-gu, Seoul, South Korea.
Yong Suk JoDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seocho-gu, Seoul, South Korea.ORCID http://orcid.org/0000-0002-6422-6530
Sung Woo ParkDivision of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Bucheon-si, Gyeonggi-do, South Korea.
Jae Ha LeeDivision of Pulmonology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Haeundae-gu, South Korea.ORCID http://orcid.org/0000-0003-0932-2826
Hyun-Kyung LeeDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, South Korea.
Song Yee KimDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul, South Korea.
Ala WooDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul, South Korea.
Yong Hyun KimDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea Bucheon St Mary's Hospital, Bucheon-si, Gyeonggi-do, South Korea.
Hongseok YooDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jong Sun ParkDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea.ORCID http://orcid.org/0000-0003-3707-3636
Hyung Koo KangDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Ji Eun KangDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Joo Hun ParkDepartment of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, South Korea.
Woo Jin KimDepartment of Internal Medicine and Environmental Health Center, Kangwon National University, Chuncheon, Gangwondo, South Korea.
Kyoung-Nam KimDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul, Seodaemun-gu, South Korea.
Jin Woo SongDepartment of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Songpa-gu, South Korea jwsongasan@gmail.com.ORCID http://orcid.org/0000-0001-5121-3522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterised by progressive fibrosis. Environmental exposures, including fine particulate matter (PM METHODS AND ANALYSIS: This prospective, multicentre cohort study involves 15 medical institutions across South Korea. A total of 120 patients with IPF have been recruited and will be followed for 1 year. The impact of indoor exposure to PM ETHICS AND DISSEMINATION: The study has been approved by the Institutional Review Boards of all institutions, including Asan Medical Center (S2021-1136-0051). Written informed consent was obtained from all participants prior to enrolment. TRIAL REGISTRATION NUMBER: KCT0008638.

Indexed as

Air Pollution, IndoorEnvironmental ExposureIdiopathic Pulmonary FibrosisParticulate MatterAgedBiomarkersDisease ProgressionFemaleHumansMaleMiddle AgedProspective StudiesRepublic of KoreaRespiratory Function TestsBiomarkersParticulate MatterIdiopathic Pulmonary FibrosisTelemedicine

Identifiers

PMID42303311
PMCPMC13289416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.